kabiven g19%
fresenius kabi new zealand limited - glucose monohydrate 20.9% equivalent to 19% glucose anhydrous; ; ; ; alanine 1.6%; ; ; ; arginine 1.13%; ; ; ; ; aspartic acid 0.34%; ; ; ; ; ; calcium chloride dihydrate 0.074%; ; glutamic acid 0.56%; ; ; ; ; ; glycine 0.79%; ; ; ; ; ; histidine 0.68%; ; ; ; ; isoleucine 0.56%; ; ; ; ; ; leucine 0.79%; ; ; ; ; ; lysine hydrochloride 0.9%; ; ; ; ; ; ; magnesium sulfate heptahydrate 0.16%; ; ; methionine 0.56%; ; ; ; ; ; phenylalanine 0.79%; ; ; ; ; ; potassium chloride 0.597%; ; proline 0.68%; ; serine 0.45%; ; ; ; ; sodium acetate trihydrate 0.49%; ; ; sodium glycerophosphate 0.54%; ; ; ; threonine 0.56%; ; ; ; tryptophan 0.19%; ; ; ; tyrosine 0.023%; ; ; ; valine 0.73%; ; ; ; ; soya oil 20% - emulsion for injection - active: glucose monohydrate 20.9% equivalent to 19% glucose anhydrous excipient: water for injection active: alanine 1.6% arginine 1.13% aspartic acid 0.34% calcium chloride dihydrate 0.074% glutamic acid 0.56% glycine 0.79% histidine 0.68% isoleucine 0.56% leucine 0.79% lysine hydrochloride 0.9% magnesium sulfate heptahydrate 0.16% methionine 0.56% phenylalanine 0.79% potassium chloride 0.597% proline 0.68% serine 0.45% sodium acetate trihydrate 0.49% sodium glycerophosphate 0.54% threonine 0.56% tryptophan 0.19% tyrosine 0.023% valine 0.73% excipient: glacial acetic acid water for injection active: soya oil 20% excipient: egg lecithin glycerol sodium hydroxide water for injection - parenteral nutrition for adult patients and children above 2 years of age when oral or enteral nutrition is impossible or insufficient or contraindicated.
kabiven g11%
fresenius kabi new zealand limited - glucose monohydrate 12.1% equivalent to 11% glucose anhydrous; ; ; ; alanine 1.6%; ; ; ; arginine 1.13%; ; ; ; ; aspartic acid 0.34%; ; ; ; ; ; calcium chloride dihydrate 0.074%; ; glutamic acid 0.56%; ; ; ; ; ; glycine 0.79%; ; ; ; ; ; histidine 0.68%; ; ; ; ; isoleucine 0.56%; ; ; ; ; ; leucine 0.79%; ; ; ; ; ; lysine hydrochloride 0.9%; ; ; ; ; ; ; magnesium sulfate heptahydrate 0.16%; ; ; methionine 0.56%; ; ; ; ; ; phenylalanine 0.79%; ; ; ; ; ; ; potassium chloride 0.597%; ; proline 0.68%; ; serine 0.45%; ; ; ; ; ; sodium acetate trihydrate 0.49%; ; ; sodium glycerophosphate 0.54%; ; ; threonine 0.56%; ; ; ; tryptophan 0.19%; ; ; ; tyrosine 0.023%; ; ; ; valine 0.73%; ; ; ; ; soya oil 20% - emulsion for injection - active: glucose monohydrate 12.1% equivalent to 11% glucose anhydrous excipient: water for injection active: alanine 1.6% arginine 1.13% aspartic acid 0.34% calcium chloride dihydrate 0.074% glutamic acid 0.56% glycine 0.79% histidine 0.68% isoleucine 0.56% leucine 0.79% lysine hydrochloride 0.9% magnesium sulfate heptahydrate 0.16% methionine 0.56% phenylalanine 0.79% potassium chloride 0.597% proline 0.68% serine 0.45% sodium acetate trihydrate 0.49% sodium glycerophosphate 0.54% threonine 0.56% tryptophan 0.19% tyrosine 0.023% valine 0.73% excipient: glacial acetic acid water for injection active: soya oil 20% excipient: egg lecithin glycerol sodium hydroxide water for injection - parenteral nutrition for adult patients and children above 2 years of age when oral or enteral nutrition is impossible or insufficient or contraindicated.
min-i-jet glucose 25g/50ml injection solution syringe vial
bppr consulting - glucose monohydrate -
glucose 5% freeflex glucose 12.5 g/250 ml injection bag
fresenius kabi australia pty ltd - glucose, quantity: 12.5 g - injection, solution - excipient ingredients: water for injections; hydrochloric acid; sodium hydroxide - the solutions are indicated for intravenous fluid therapy designed to correct deficiencies in energy levels. glucose 5% is also used to correct hydration levels. the solutions may also be used as solvents for intravenously administered drugs where compatibility has been established.
glucose 5% freeflex glucose 5g/100ml injection bag
fresenius kabi australia pty ltd - glucose, quantity: 5 g - injection, solution - excipient ingredients: water for injections; sodium hydroxide; hydrochloric acid - the solutions are indicated for intravenous fluid therapy designed to correct deficiencies in energy levels. glucose 5% is also used to correct hydration levels. the solutions may also be used as solvents for intravenously administered drugs where compatibility has been established.
glucose 5% freeflex glucose 2.5g/50ml injection bag
fresenius kabi australia pty ltd - glucose, quantity: 2.5 g - injection, solution - excipient ingredients: water for injections; sodium hydroxide; hydrochloric acid - the solutions are indicated for intravenous fluid therapy designed to correct deficiencies in energy levels. glucose 5% is also used to correct hydration levels. the solutions may also be used as solvents for intravenously administered drugs where compatibility has been established.
finomel 1435ml intravenous infusion bag (10% amino acid with electrolyte 42% glucose and 20% lipid emulsion)
baxter healthcare pty ltd - soya oil, quantity: 16.38 g; olive oil, quantity: 13.65 g; medium chain triglycerides, quantity: 13.65 g; fish oil - rich in omega-3 acids, quantity: 10.92 g - injection, emulsion - excipient ingredients: egg lecithin; glycerol; sodium oleate; dl-alpha-tocopherol; sodium hydroxide; water for injections - finomel is indicated for parenteral nutrition in adult patients when oral or enteral nutrition is impossible, insufficient or contraindicated.
finomel 1085ml intravenous infusion bag (10% amino acid with electrolyte 42% glucose and 20% lipid emulsion)
baxter healthcare pty ltd - soya oil, quantity: 12.36 g; olive oil, quantity: 10.3 g; medium chain triglycerides, quantity: 10.3 g; fish oil - rich in omega-3 acids, quantity: 8.24 g - injection, emulsion - excipient ingredients: egg lecithin; glycerol; sodium oleate; dl-alpha-tocopherol; sodium hydroxide; water for injections - finomel is indicated for parenteral nutrition in adult patients when oral or enteral nutrition is impossible, insufficient or contraindicated.
dextron injectable glucose solution
nutrien ag solutions limited - glucose - parenteral liquid/solution/suspension - glucose carbohydrate active 400.0 g/l - nutrition & metabolism - cattle | sheep pregnant | beef | bos indicus | bos taurus | bovine | buffalo | bull | bullock | calf | cow | dairy cow | heifer - ketosis | mineral and nutritional additive | acetonaemia | actinobacillosis | amino acid supplement | amino acids | bone fragility | bone growth | calcium supplement | cartilage strength | copper deficiency | egg shell | elevated ketones | fatty acid deficiency | fatty liver | glucose | grass tetany | hepatotoxic drugs | hypocalcaemia | hypomagnesaemia | ileitis | iodine deficiencies | lactating | laxative | l-carnitine supplement | liver abscess | liver damage | lysine deficiencies | milk fever | mineral additive | myopathies | myositis syndrome | non-clinical ketosis | pangamic acid | phosphorous supplement | rickets | selenium deficiency | shell strength | soft bone disease | vitamin b12 | vitamin d supplement | vitamin e deficiencies | zinc deficiencies
physioneal 40 glucose 1.36 % wv
baxter healthcare distribution ltd., israel - calcium chloride dihydrate; glucose monohydrate (as anhydrous); lactic acid as sodium; magnesium chloride hexahydrate; sodium bicarbonate; sodium chloride - solution for peritoneal dialysis - sodium chloride 5.38 g/l; magnesium chloride hexahydrate 0.051 g/l; lactic acid as sodium 1.68 g/l; sodium bicarbonate 2.10 g/l; glucose monohydrate (as anhydrous) 13.6 g/l; calcium chloride dihydrate 0.184 g/l - sodium chloride - sodium chloride - physioneal is indicated whenever peritoneal dialysis is employed including:acute and chronic renal failure severe water retention severe electrolyte imbalance drug intoxication with dialysable substances when a more adequate therapeutic alternative is not available. bicarbonate/lactate based physioneal peritoneal dialysis solutions with a physiological ph are particularly indicated in patients in whom solutions based on lactate buffer only with a low ph cause abdominal inflow pain or discomfort.